申请人:Kyowa Hakko Kogyo Co., Ltd.
公开号:US04588729A1
公开(公告)日:1986-05-13
Offered is an anticonvulsive composition which comprises an effective amount of a dihydrouracil derivative represented by the formula: ##STR1## [wherein one of A and B is ##STR2## (wherein Y.sub.1, Y.sub.2 and Y.sub.3 are hydrogen atoms, lower alkyl groups, halogen atoms, nitro groups, amino groups, carboxyl groups, lower alkoxycarbonyl groups or trifluoromethyl groups), a naphthyl group or a diphenylmethyl group, and the other is a hydrogen atom, a lower alkyl group, a lower alkenyl group, a cyclopentyl group, a cyclohexyl group or ##STR3## (wherein Z.sub.1, Z.sub.2 and Z.sub.3 are hydrogen atoms, lower alkyl groups, halogen atoms or trifluoromethyl groups), R.sub.1, R.sub.2 and R.sub.3 are hydrogen atoms or lower alkyl groups, and X is an oxygen atom or a sulfur atom] and at least one pharmaceutically acceptable carrier.
提供了一种抗惊厥组合物,其包括有效量的二氢尿嘧啶衍生物,其由以下式子表示:##STR1##[其中A和B中的一个是##STR2##(其中Y.sub.1,Y.sub.2和Y.sub.3是氢原子,低烷基,卤素原子,硝基,氨基,羧基,低烷氧羰基或三氟甲基基团),萘基或二苯甲基基团,另一个是氢原子,低烷基,低烯基,环戊基,环己基或##STR3##(其中Z.sub.1,Z.sub.2和Z.sub.3是氢原子,低烷基,卤素原子或三氟甲基基团),R.sub.1,R.sub.2和R.sub.3是氢原子或低烷基,X是氧原子或硫原子],以及至少一种药学上可接受的载体。